The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1002
June 6, 1997
View Complete Issue         Table of Contents 2019 
Pentosan for Interstitial Cystitis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Pentosan for Interstitial Cystitis
June 6, 1997 (Issue: 1002)
Pentosan polysulfate sodium (Elmiron - Baker Norton), a semi-synthetic mucopolysaccharide structurally similar to heparin, has been approved by the US Food and Drug Administration for oral treatment of interstitial cystitis.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Pentosan for Interstitial Cystitis
Article code: 1002c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.